Rheumatoid arthritis (RA) is on the rise. In fact, a recent global study in Lancet Rheumatology predicts that RA cases are ...
13d
Hosted on MSNFDA grants 510(k) clearance to Targeted Genomics’ GlutenID testThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Targeted Genomics’ GlutenID test, designed to ...
Heart disease is the number one killer of men and women, but it often presents differently depending on sex. There are sex ...
Targeted Genomics LLC, a family owned genetic testing Company, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its Direct-to-Consumer GlutenID test. GlutenID ...
The outcome of HIV infection is strongly influenced by the particular HLA genes expressed by the infected individual. Certain HLA alleles, such as HLA-B57 and HLA-B27, are strongly associated with ...
Nalagenetics, a spin-off from A*STAR GIS, will be implementing a nationwide genetic screening programme in Indonesia with their PGx1301 diagnostic kit for leprosy patients. Set to launch in the fourth ...
The program will use NalaGenetics' PGx test to screen leprosy patients for the HLA-B*13:01 allele, which has been linked with a serious hypersensitivity reaction.
Inhibition of nonsense-mediated decay turns immunologically cold tumors hot by increasing the amount of mutant RNA leading to an increase in T-cell-targetable neoantigens on the cell surface.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results